Assessing the Genomic Landscape of Cervical Cancers: Clinical Opportunities and Therapeutic Targets

Claire F. Friedman, Vignesh Ravichandran, Kathryn Miller, Chad Vanderbilt, Qin Zhou, Alexia Iasonos, Malavika Vivek, Pamela Mishra, Mario M. Leitão, Vance Broach, Yukio Sonoda, Chrisann Kyi, Dmitriy Zamarin, Roisin E. O’Cearbhaill, Jason Konner, Michael F. Berger, Britta Weigelt, Amir Momeni Boroujeni, Kay J. Park, Carol Aghajanian, David B. Solit, Mark T.a. DonoghueClinical 2023 · DOI

Abstract

Tumor genomic profiling can facilitate the selection of targeted/immunotherapies, as well as clinical trial enrollment, for patients with cervical cancer.
BibTeX
@inproceedings{friedman2023assessing,
  author = {Claire F. Friedman and Vignesh Ravichandran and Kathryn Miller and Chad Vanderbilt and Qin Zhou and Alexia Iasonos and Malavika Vivek and Pamela Mishra and Mario M. Leitão and Vance Broach and Yukio Sonoda and Chrisann Kyi and Dmitriy Zamarin and Roisin E. O’Cearbhaill and Jason Konner and Michael F. Berger and Britta Weigelt and Amir Momeni Boroujeni and Kay J. Park and Carol Aghajanian and David B. Solit and Mark T.A. Donoghue},
  title = {{Assessing the Genomic Landscape of Cervical Cancers: Clinical Opportunities and Therapeutic Targets}},
  booktitle = {Clinical},
  year = {2023},
  doi = {10.1158/1078-0432.ccr-23-1078},
}

Loading related content...

Figure